Your browser doesn't support javascript.
loading
Serum soluble TREM2 is an independent biomarker associated with coronary heart disease.
Liu, Wenwu; Weng, Shuwei; Liu, Huixing; Cao, Chenghui; Wang, Shuai; Wu, Sha; He, Jia; Yang, Yang; Hu, Die; Luo, Yonghong; Peng, Daoquan.
Affiliation
  • Liu W; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Weng S; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Liu H; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Cao C; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Wang S; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Wu S; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • He J; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Yang Y; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Hu D; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Luo Y; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Peng D; Department of Cardiovascular Medicine, Research Institute of Blood Lipids and Atherosclerosis, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China. Electronic address: pengdq@csu.edu.cn.
Clin Chim Acta ; 548: 117499, 2023 Aug 01.
Article in En | MEDLINE | ID: mdl-37536519
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Disease / Atherosclerosis Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Chim Acta Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Disease / Atherosclerosis Type of study: Diagnostic_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Clin Chim Acta Year: 2023 Document type: Article Affiliation country: Country of publication: